Camber Capital Management LP United Therapeutics Corp Transaction History

Camber Capital Management LP

  • $3.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$78.31 - $95.34 $31.3 Million - $38.1 Million
-400,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$74.85 - $85.99 $2.43 Million - $2.79 Million
32,471 Added 8.83%
400,000 $31.9 Million
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $28 Million - $44.4 Million
367,529 New
367,529 $28.7 Million

Others Institutions Holding UTHR

# of Institutions
678
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email